GO:0004491 methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004491 describes the acylating, NAD+-dependent oxidation of 2-methyl-3-oxopropanoate (and malonate) to propanoyl-CoA, with bicarbonate released as the final product.
• The reaction proceeds in two steps: decarboxylation precedes CoA binding, and the enzyme can also act as a CoA- and NADH-dependent esterase.
• MSDH is a member of the aldehyde dehydrogenase superfamily and is encoded by mmsA in Pseudomonas aeruginosa and msdA in Streptomyces coelicolor.
• Ligand binding (NAD+, CoA) induces conformational changes that trigger early NADH release, a key regulatory feature of the catalytic cycle.
• MSDH paralogs are found in extremophiles such as Sulfolobus solfataricus, where they contribute to aldehyde metabolism.
• The enzyme participates in valine, isoleucine, and propionate catabolism, and its dysfunction is linked to methylmalonic acidemia and related metabolic disorders.
Description
Methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity, encoded by GO:0004491, is a molecular function that catalyzes the oxidative decarboxylation of 2-methyl-3-oxopropanoate to propanoyl-CoA, using NAD+ as an electron acceptor and coenzyme A as an acyl acceptor. This activity is central to the catabolism of branched-chain amino acids and propionate, and it is widely distributed across bacteria, fungi, and higher organisms. The enzyme is also known as MMSA dehydrogenase or MSDH and belongs to the aldehyde dehydrogenase superfamily. Researchers study GO:0004491 because it represents a critical metabolic node linking amino acid degradation to the tricarboxylic acid cycle and because its dysfunction is associated with inherited metabolic disorders such as methylmalonic acidemia. The reaction mechanism is unusual in that decarboxylation occurs before CoA binding, and bicarbonate rather than CO2 is released as the final product. This mechanistic feature has made MSDH a model system for understanding acylating aldehyde dehydrogenases and for developing enzyme inhibitors. In this article, we synthesize authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0004491, covering its definition, mechanism, key genes, disease relevance, and experimental methods including CRISPR-based models.
methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity At A Glance
| GO ID | GO:0004491 |
|---|---|
| GO term | methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity |
| Ontology | molecular_function |
| Synonym | MMSA dehydrogenase activity; MSDH activity; methylmalonate-semialdehyde dehydrogenase (acylating) activity |
| Major function | Oxidative decarboxylation of 2-methyl-3-oxopropanoate to propanoyl-CoA, with NAD+ as electron acceptor and CoA as acyl acceptor |
| Alternative substrate | Malonate (3-oxopropanoate) |
| Reaction products | Propanoyl-CoA, hydrogencarbonate (bicarbonate), NADH, H+ |
| Mechanistic feature | Decarboxylation precedes CoA binding; bicarbonate is released as final product |
| Enzyme family | Aldehyde dehydrogenase superfamily |
What Is GO:0004491?
GO:0004491 is defined as the catalysis of the reaction: 2-methyl-3-oxopropanoate + CoA + NAD+ = propanoyl-CoA + hydrogencarbonate + NADH + H+. The enzyme can also use malonate (3-oxopropanoate) as a substrate. The reaction occurs in two steps, with decarboxylation preceding CoA binding, and bicarbonate rather than CO2 is released as the final product.
Why Is methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity Important in Cell Biology?
GO:0004491 is important because it governs a key step in the catabolism of valine, isoleucine, and propionate, connecting these pathways to central energy metabolism. The enzyme's unique acylating mechanism and its ability to use malonate as a substrate make it a valuable target for mechanistic enzymology and for understanding metabolic disorders such as methylmalonic acidemia.
• Catalyzes a critical step in valine, isoleucine, and propionate catabolism.
• Links amino acid degradation to the tricarboxylic acid cycle via propanoyl-CoA.
• Dysfunction is associated with methylmalonic acidemia and related metabolic disorders.
• Serves as a model enzyme for studying acylating aldehyde dehydrogenases.
• Exhibits CoA- and NADH-dependent esterase activity, expanding its functional repertoire.
• Ligand-induced conformational changes regulate NADH release, a key regulatory mechanism.
• Paralogs in extremophiles like Sulfolobus solfataricus highlight evolutionary adaptation.
• Potential target for antimicrobial and metabolic disease therapeutics.
• Involved in degradation of xenobiotic compounds such as 3-chloro-2-methylpropionic acid.
• Provides a biochemical marker for metabolic engineering and synthetic biology applications.
What Happens During methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity?
Substrate Binding and Decarboxylation
In simple terms: The enzyme first grabs the substrate and removes a carbon dioxide piece before attaching coenzyme A.
The reaction begins with the binding of 2-methyl-3-oxopropanoate (or malonate) to the active site of MSDH. In the first step, decarboxylation occurs, releasing bicarbonate rather than CO2. This step is NAD+-dependent and generates a reactive intermediate that is subsequently acylated by coenzyme A.
CoA Binding and Acyl Transfer
In simple terms: After decarboxylation, coenzyme A attaches to the remaining molecule to form propanoyl-CoA.
Following decarboxylation, coenzyme A binds to the enzyme-substrate complex, and the acyl group is transferred to CoA, forming propanoyl-CoA. This step is coupled to the reduction of NAD+ to NADH. The enzyme can also catalyze a reverse esterase reaction, hydrolyzing propanoyl-CoA in the presence of NADH.
NADH Release and Conformational Changes
In simple terms: The enzyme changes shape to let go of the used electron carrier NADH.
Ligand binding, particularly adenine nucleotide binding, triggers conformational changes that promote the early release of NADH from the enzyme. This regulatory mechanism ensures efficient turnover and prevents product inhibition.
Substrate Specificity and Alternative Reactions
In simple terms: The enzyme can also work on a similar molecule called malonate and even act as an esterase.
MSDH can use malonate (3-oxopropanoate) as an alternative substrate, converting it to acetyl-CoA. Additionally, the enzyme exhibits CoA- and NADH-dependent esterase activity, hydrolyzing acyl-CoA esters. This dual functionality suggests a broader role in acyl-CoA metabolism.
Enzyme Structure and Active Site
In simple terms: The enzyme is built from protein subunits with a special pocket that holds the substrate and cofactors.
MSDH is a member of the aldehyde dehydrogenase superfamily and typically forms homotetramers or homodimers. The active site contains conserved cysteine and glutamate residues essential for catalysis. Structural studies of Bacillus subtilis MSDH have revealed the molecular basis for substrate recognition and cofactor binding.
Key Genes Involved in GO:0004491 methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity
The following genes encode methylmalonate-semialdehyde dehydrogenase or related enzymes across different organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| mmsA (Pseudomonas aeruginosa) | Encodes MSDH in the mmsAB operon | Model for bacterial propionate metabolism |
| mmsB (Pseudomonas aeruginosa) | Encodes 3-hydroxyisobutyrate dehydrogenase | Part of the mmsAB operon for valine catabolism |
| msdA (Streptomyces coelicolor) | Encodes methylmalonic acid semialdehyde dehydrogenase | First characterized msdA gene in actinobacteria |
| MSDH (Bacillus subtilis) | Methylmalonate-semialdehyde dehydrogenase | Mechanistic studies of acylating aldehyde dehydrogenase |
| MSDH (Homo sapiens) | Mitochondrial MSDH | Associated with methylmalonic acidemia |
| ALDH6A1 (Homo sapiens) | Aldehyde dehydrogenase 6 family member A1 | Human ortholog of MSDH |
| mmsA (Xanthobacter sp. CIMW 99) | Degradation of 3-chloro-2-methylpropionic acid | Biodegradation of xenobiotics |
| MSDH paralogs (Sulfolobus solfataricus) | Aldehyde metabolism in extremophiles | Evolutionary studies of ALDH superfamily |
| mmsA (Bacillus subtilis) | MSDH enzyme | Biochemical and structural studies |
| msdA (Streptomyces coelicolor) | MSDH enzyme | Gene cloning and characterization |
| mmsB (Pseudomonas aeruginosa) | 3-hydroxyisobutyrate dehydrogenase | Operon regulation |
| ALDH6A1 (Mus musculus) | Mouse MSDH | Animal models of metabolic disorders |
| mmsA (Pseudomonas putida) | MSDH | Biodegradation pathways |
| MSDH (Rattus norvegicus) | Rat MSDH | Enzyme kinetics and regulation |
| mmsA (Escherichia coli) | Putative MSDH | Metabolic engineering |
| MSDH (Saccharomyces cerevisiae) | Yeast MSDH | Eukaryotic model for propionate metabolism |
How Is methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity Regulated?
MSDH activity is regulated by ligand binding, particularly NAD+ and CoA, which induce conformational changes that control NADH release. The enzyme's expression is also subject to regulation by the mmsAB operon in Pseudomonas aeruginosa, which responds to the availability of valine and isoleucine. In Streptomyces coelicolor, msdA expression is induced by propionate.
methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ALDH6A1 | Methylmalonic acidemia | Knockout mouse model |
| mmsA | Propionate metabolism defects | Bacterial knockout |
| msdA | Streptomyces secondary metabolism | Gene deletion in S. coelicolor |
| MSDH | Metabolic disorders | Patient-derived fibroblasts |
| mmsA | Xenobiotic degradation | Xanthobacter sp. CIMW 99 |
Methylmalonic Acidemia
Mutations in the human MSDH gene (ALDH6A1) or its associated pathways can lead to methylmalonic acidemia, a metabolic disorder characterized by accumulation of methylmalonic acid. This condition presents with vomiting, lethargy, and developmental delay, and can be life-threatening if untreated.
Propionic Acidemia
Defects in propionate catabolism, in which MSDH participates, can cause propionic acidemia, another inherited metabolic disorder. Symptoms include poor feeding, vomiting, and neurological impairment.
Cancer Metabolism
Altered expression of aldehyde dehydrogenases, including MSDH, has been observed in some cancers, where they may contribute to metabolic reprogramming. However, direct evidence linking GO:0004491 to cancer remains limited and requires further investigation.
From methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Enzyme kinetics and mechanism | Purified recombinant MSDH |
| Role in valine catabolism | mmsA knockout in Pseudomonas aeruginosa |
| Human disease modeling | ALDH6A1 knockout iPSCs |
| Substrate specificity | Point mutations in active site residues |
| Regulation by NAD+/CoA | Tagged knock-in for FRET sensors |
| Evolutionary conservation | Paralog overexpression in Sulfolobus |
How to Study the methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADH absorbance assay | Enzyme activity | Kinetic characterization |
| X-ray crystallography | Three-dimensional structure | Active site analysis |
| Site-directed mutagenesis | Role of specific residues | Mechanistic studies |
| RT-qPCR | mRNA expression levels | Gene regulation |
| RNA-seq | Transcriptome-wide expression | Pathway analysis |
| Isothermal titration calorimetry | Binding affinity | Ligand interactions |
| Mass spectrometry | Product identification | Metabolite profiling |
Enzyme Kinetics and Spectrophotometry
MSDH activity is typically measured by monitoring NADH production at 340 nm using purified enzyme and substrates. This method allows determination of kinetic parameters and substrate specificity.
Structural Biology
X-ray crystallography and cryo-EM have been used to solve structures of MSDH from Bacillus subtilis and other organisms, revealing active site architecture and conformational changes upon ligand binding.
Site-Directed Mutagenesis
Mutating conserved residues in the active site (e.g., cysteine, glutamate) helps identify catalytic mechanisms and substrate binding determinants.
Gene Expression Analysis
RT-qPCR and RNA-seq are used to measure mmsA/msdA expression under different growth conditions, such as propionate induction.
How CRISPR Can Be Used to Study GO:0004491 methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity
Knockout
CRISPR-Cas9 knockout of mmsA or ALDH6A1 can be used to study loss-of-function phenotypes, such as accumulation of methylmalonate semialdehyde and metabolic flux changes. Knockout cell lines are valuable for validating enzyme function in vivo.
Point Mutation
Introducing point mutations in catalytic residues (e.g., Cys or Glu) via CRISPR base editing or HDR can dissect the mechanism of decarboxylation and CoA transfer. Such models help distinguish between substrate binding and catalysis.
Knock-in
Knock-in of tagged MSDH (e.g., FLAG or GFP) allows for affinity purification and live-cell imaging to study localization and interactions. This approach is useful for tracking enzyme dynamics.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase MSDH levels to study its role in metabolic pathways and potential toxicity. Overexpression models are also used for drug screening.
How EDITGENE Supports methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity Research
Researchers studying methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity-related genes often need to determine whether a candidate gene is causally involved in metabolic pathways or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity research.
Frequently Asked Questions About methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity
What is methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity?
It is a molecular function (GO:0004491) that catalyzes the oxidative decarboxylation of 2-methyl-3-oxopropanoate to propanoyl-CoA, using NAD+ and coenzyme A.
What genes are involved in methylmalonate-semialdehyde dehydrogenase (acylating, NAD+) activity?
Key genes include mmsA in Pseudomonas aeruginosa, msdA in Streptomyces coelicolor, and ALDH6A1 in humans.
What is the reaction catalyzed by GO:0004491?
The reaction is: 2-methyl-3-oxopropanoate + CoA + NAD+ = propanoyl-CoA + hydrogencarbonate + NADH + H+.
Can MSDH use malonate as a substrate?
Yes, MSDH can also use malonate (3-oxopropanoate) as a substrate.
What is the mechanism of MSDH?
The reaction occurs in two steps: decarboxylation precedes CoA binding, and bicarbonate is released as the final product.
How is MSDH regulated?
MSDH is regulated by ligand binding, particularly NAD+ and CoA, which induce conformational changes that trigger NADH release.
What diseases are associated with MSDH dysfunction?
Dysfunction of MSDH is associated with methylmalonic acidemia and propionic acidemia.
How can I study MSDH activity in the lab?
Common methods include NADH absorbance assays, site-directed mutagenesis, and structural biology.
What CRISPR models are available for MSDH research?
Knockout, point mutation, knock-in, and overexpression models can be generated using CRISPR-Cas9.
Where can I find MSDH gene sequences?
Sequences are available in NCBI GenBank for mmsA, msdA, and ALDH6A1.
Conclusion
GO:0004491 represents a mechanistically unique and metabolically critical enzyme activity. Its role in amino acid and propionate catabolism, coupled with its association with inherited metabolic disorders, makes it a compelling target for both basic and translational research. Advances in CRISPR-based models and structural biology continue to illuminate the finer details of MSDH function and regulation.
References
- 1. Popov KM et al.. 1992. Coenzyme A- and NADH-dependent esterase activity of methylmalonate semialdehyde dehydrogenase.. Biochim Biophys Acta 1119(1):69-73 PMID: 1540637
- 2. Stines-Chaumeil C et al.. 2006. Mechanistic characterization of the MSDH (methylmalonate semialdehyde dehydrogenase) from Bacillus subtilis.. Biochem J 395(1):107-15 PMID: 16332250
- 3. Kedishvili NY et al.. 1991. The effect of ligand binding on the proteolytic pattern of methylmalonate semialdehyde dehydrogenase.. Arch Biochem Biophys 290(1):21-6 PMID: 1898092
- 4. Steele MI et al.. 1992. Characterization of the mmsAB operon of Pseudomonas aeruginosa PAO encoding methylmalonate-semialdehyde dehydrogenase and 3-hydroxyisobutyrate dehydrogenase.. J Biol Chem 267(19):13585-92 PMID: 1339433
- 5. Bchini R et al.. 2012. Adenine binding mode is a key factor in triggering the early release of NADH in coenzyme A-dependent methylmalonate semialdehyde dehydrogenase.. J Biol Chem 287(37):31095-103 PMID: 22782904
- 6. Esser D et al.. 2013. Unraveling the function of paralogs of the aldehyde dehydrogenase super family from Sulfolobus solfataricus.. Extremophiles 17(2):205-16 PMID: 23296511
- 7. Zhang YX et al.. 1996. Cloning and characterization of a gene (msdA) encoding methylmalonic acid semialdehyde dehydrogenase from Streptomyces coelicolor.. J Bacteriol 178(2):490-5 PMID: 8550471
- 8. Smith MR et al.. 1991. Degradation of 3-chloro-2-methylpropionic acid by Xanthobacter sp. CIMW 99.. Appl Microbiol Biotechnol 36(2):246-51 PMID: 1368112
